UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma

Frontiers in genetics, 2022-07, Vol.13, p.938259-938259

2022

Volltextzugriff (PDF)

miR-539 inhibits prostate cancer progression by directly targeting SPAG5

Journal of experimental & clinical cancer research, 2016-04, Vol.35 (60), p.60-60, Article 60

2016

Volltextzugriff (PDF)

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis

PloS one, 2013-07, Vol.8 (7), p.e68634-e68634

2013

Volltextzugriff (PDF)

Macrophage-targeted and clearable glutathione-based MRI nanoprobes for atherosclerosis molecular imaging

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2019-11, Vol.21 (11), Article 231

2019

Volltextzugriff (PDF)

Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization

Frontiers in immunology, 2024, Vol.15, p.1342658-1342658

2024

Volltextzugriff (PDF)

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs

Frontiers in immunology, 2022-07, Vol.13, p.916800-916800

2022

Volltextzugriff (PDF)

Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer

Cancer cell international, 2024-08, Vol.24 (1), p.294-25

2024

Volltextzugriff (PDF)

Clinical significance of NUCB2 mRNA expression in prostate cancer

Journal of experimental & clinical cancer research, 2013-08, Vol.32 (1), p.56-56, Article 56

2013

Volltextzugriff (PDF)

Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis

PloS one, 2013-03, Vol.8 (3), p.e58170-e58170

2013

Volltextzugriff (PDF)

Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis

PloS one, 2013-07, Vol.8 (7), p.e69366-e69366

2013

Volltextzugriff (PDF)

CircGNG4 Promotes the Progression of Prostate Cancer by Sponging miR-223 to Enhance EYA3/c-myc Expression

Frontiers in cell and developmental biology, 2021-07, Vol.9, p.684125-684125

2021

Volltextzugriff (PDF)

Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy

World journal of surgical oncology, 2020-08, Vol.18 (1), p.201-201, Article 201

2020

Volltextzugriff (PDF)

Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer

International journal of molecular sciences, 2014-07, Vol.15 (7), p.11665-11677

2014

Volltextzugriff (PDF)

CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy

Frontiers in oncology, 2023-06, Vol.13, p.1170397-1170397

2023

Volltextzugriff (PDF)

Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer

PloS one, 2014-03, Vol.9 (3), p.e91069-e91069

2014

Volltextzugriff (PDF)

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

BMC immunology, 2012-03, Vol.13 (1), p.14-14, Article 14

2012

Volltextzugriff (PDF)

Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis

PloS one, 2012-08, Vol.7 (8), p.e42387-e42387

2012

Volltextzugriff (PDF)

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls

BMC cancer, 2011-09, Vol.11 (1), p.391-391, Article 391

2011

Volltextzugriff (PDF)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression

Oncotarget, 2015-03, Vol.6 (8), p.6092-6104

2015

Volltextzugriff (PDF)

MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathway

Cancer biomarkers : section A of Disease markers, 2022-01, Vol.35 (1), p.83-98

2022

Volltextzugriff (PDF)

Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer

Aging (Albany, NY.), 2023-12, Vol.15 (24), p.15134-15160

2023

Volltextzugriff (PDF)

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

OncoTargets and therapy, 2018, Vol.11, p.3853-3867

2018

Volltextzugriff (PDF)

Anoikis-related gene signature as novel prognostic biomarker to predict immunotherapy with bladder urothelial carcinoma

Oncologie (Paris, France), 2023-05, Vol.25 (3), p.291-308

2023

Volltextzugriff (PDF)

High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer

Tumor biology, 2014-03, Vol.35 (3), p.2025-2028

2014

Volltextzugriff (PDF)

Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer

Journal of experimental & clinical cancer research, 2013-10, Vol.32 (1), p.77-77, Article 77

2013

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(5)
Journal Of Experimental & Clinical Cancer Research
(4)
Tumor Biology
(3)
Frontiers In Immunology
(2)
Oncotarget
(2)
Urologia Internationalis
(2)
Aging
(1)
Bjui
(1)
Bmc Cancer
(1)
Bmc Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma

miR-539 inhibits prostate cancer progression by directly targeting SPAG5

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis

Macrophage-targeted and clearable glutathione-based MRI nanoprobes for atherosclerosis molecular imaging

Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs

Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer

Clinical significance of NUCB2 mRNA expression in prostate cancer

Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis

Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis

CircGNG4 Promotes the Progression of Prostate Cancer by Sponging miR-223 to Enhance EYA3/c-myc Expression

Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy

Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer

CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy

Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression

MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathway

Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

Anoikis-related gene signature as novel prognostic biomarker to predict immunotherapy with bladder urothelial carcinoma

High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer

Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer

Suchergebnisse filtern